论文部分内容阅读
目的:针对非典型骨转移肿瘤患者采用99TCm-MDP SPECTCT图像融合诊断的实际临床价值进行分析。方法:针对我院在2016年1月—2017年1月间按照常规99TC-MDP检测诊断为非典型骨转移94例为样本,均给予SPECTCT图像融合检测并给予CT检测,针对SPECT、SPECT/CT以及CT检测结果上差异性进行分析。结果:经临床最终确诊,本组患者中共涉及106个病灶,且三种检测方式阳性率存在有显著差异,P<0.05具备统计学意义。在诊断符合率上,SPECT为51.88%(55/106),常规CT检测符合率为77.36%(82/106),SPECT/CT诊断符合率为94.34%(100/106),P<0.05差异具备统计学意义。结论:SPECT/CT图像融合在诊断非典型骨转移肿瘤中具备较好的准确性,能帮助患者尽快确诊,提升诊断效率。
Objective: To analyze the clinical value of 99TCm-MDP SPECTCT image fusion in patients with atypical bone metastases. Methods: Ninety-four patients with atypical bone metastases diagnosed as 99TC-MDP in our hospital from January 2016 to January 2017 were enrolled in this study. All patients were given SPECTCT image fusion and CT examination. SPECT, SPECT / CT And CT test results on the differences were analyzed. Results: The final diagnosis of clinical, the total number of 106 patients involved in this group of patients, and the positive rate of the three test there is a significant difference, P <0.05 with statistical significance. The coincidence rate of SPECT and CT was 51.88% (55/106). The coincidence rate of routine CT examination was 77.36% (82/106). The coincidence rate of SPECT / CT was 94.34% (100/106) Statistical significance. Conclusion: SPECT / CT image fusion has good accuracy in the diagnosis of atypical bone metastases, which can help patients diagnose as soon as possible and improve the diagnostic efficiency.